Friday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025

The Market Herald
04-04

The ASX has been down 1.5% at 7,739 points this morning.

There’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.

Staples and Health Care are the only sectors in positive territory so far.

In company news, Mesoblast (ASX:MSB) has been among the most watched on HotCopper forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.

Orthocell (ASX:OCC) has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.

And, finally, Bellevue Gold (ASX:BGL) has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.

More market news

Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”

Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst

Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10